NT-proBNP and exercise capacity in adult patients with congenital heart disease and a prosthetic valve: a multicentre PROSTAVA study

go back to reference van Veldhuisen DJ, Linssen GC, Jaarsma T, et al. B‑type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol. 2013;61:1498–506.CrossRefPubMed van Veldhuisen DJ, Linssen GC, Jaarsma T, et al. B‑type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol. 2013;61:1498–506.CrossRefPubMed

go back to reference Scrutinio D, Ammirati E, Guida P, et al. Clinical utility of N‑terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score. Int J Cardiol. 2013;168:2120–6.CrossRefPubMed Scrutinio D, Ammirati E, Guida P, et al. Clinical utility of N‑terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score. Int J Cardiol. 2013;168:2120–6.CrossRefPubMed

go back to reference Oremus M, Don-Wauchope A, McKelvie R, et al. BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure. Heart Fail Rev. 2014;19:471–505.CrossRefPubMed Oremus M, Don-Wauchope A, McKelvie R, et al. BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure. Heart Fail Rev. 2014;19:471–505.CrossRefPubMed

go back to reference Melina G, Angeloni E, Benedetto U, et al. Relationship between prosthesis patient mismatch and pro-brain natriuretic peptides after aortic valve replacement. J Heart Valve Dis. 2010;19:171–6.PubMed Melina G, Angeloni E, Benedetto U, et al. Relationship between prosthesis patient mismatch and pro-brain natriuretic peptides after aortic valve replacement. J Heart Valve Dis. 2010;19:171–6.PubMed

go back to reference Eindhoven JA, van den Bosch AE, Ruys TP, et al. N‑terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease. J Am Coll Cardiol. 2013;62:1203–12.CrossRefPubMed Eindhoven JA, van den Bosch AE, Ruys TP, et al. N‑terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease. J Am Coll Cardiol. 2013;62:1203–12.CrossRefPubMed

go back to reference van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58:2241–7.CrossRefPubMed van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58:2241–7.CrossRefPubMed

go back to reference Diller GP, Kempny A, Alonso-Gonzalez R, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation. 2015;132:2118–25.CrossRefPubMed Diller GP, Kempny A, Alonso-Gonzalez R, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation. 2015;132:2118–25.CrossRefPubMed

go back to reference Pibarot P, Dumesnil JG, Cartier PC, Metras J, Lemieux MD. Patient-prosthesis mismatch can be predicted at the time of operation. Ann Thorac Surg. 2001;71(5 Suppl):265–8.CrossRef Pibarot P, Dumesnil JG, Cartier PC, Metras J, Lemieux MD. Patient-prosthesis mismatch can be predicted at the time of operation. Ann Thorac Surg. 2001;71(5 Suppl):265–8.CrossRef

go back to reference O’Byrne ML, Glatz AC, Mercer-Rosa L, Gillespie MJ, Dori Y, Goldmuntz E, et al. Trends in pulmonary valve replacement in children and adults with tetralogy of fallot. Am J Cardiol. 2015;115:118–24.CrossRefPubMed O’Byrne ML, Glatz AC, Mercer-Rosa L, Gillespie MJ, Dori Y, Goldmuntz E, et al. Trends in pulmonary valve replacement in children and adults with tetralogy of fallot. Am J Cardiol. 2015;115:118–24.CrossRefPubMed

go back to reference van der Velde ET, Vriend JW, Mannens MM, Uiterwaal CS, Brand R, Mulder BJ. CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results. Eur J Epidemiol. 2005;20:549–57.CrossRefPubMed van der Velde ET, Vriend JW, Mannens MM, Uiterwaal CS, Brand R, Mulder BJ. CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results. Eur J Epidemiol. 2005;20:549–57.CrossRefPubMed

go back to reference Freling HG, van Slooten YJ, van Melle JP, et al. Prosthetic valves in adult patients with congenital heart disease: rationale and design of the Dutch PROSTAVA study. Neth Heart J. 2012;20:419–24.CrossRefPubMedPubMedCentral Freling HG, van Slooten YJ, van Melle JP, et al. Prosthetic valves in adult patients with congenital heart disease: rationale and design of the Dutch PROSTAVA study. Neth Heart J. 2012;20:419–24.CrossRefPubMedPubMedCentral

go back to reference McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69.CrossRefPubMed McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69.CrossRefPubMed

go back to reference Zoghbi WA, Chambers JB, Dumesnil JG, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report from the American Society of Echocardiography’s Guidelines and standards committee and the task force on prosthetic valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2009;22:975–1014, quiz 1082–1084.CrossRefPubMed Zoghbi WA, Chambers JB, Dumesnil JG, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report from the American Society of Echocardiography’s Guidelines and standards committee and the task force on prosthetic valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2009;22:975–1014, quiz 1082–1084.CrossRefPubMed

go back to reference Capps SB, Elkins RC, Fronk DM. Body surface area as a predictor of aortic and pulmonary valve diameter. J Thorac Cardiovasc Surg. 2000;119:975–82.CrossRefPubMed Capps SB, Elkins RC, Fronk DM. Body surface area as a predictor of aortic and pulmonary valve diameter. J Thorac Cardiovasc Surg. 2000;119:975–82.CrossRefPubMed

go back to reference Ascoop CAPL, Van Zeijl LGPM, Pool J, Simoons ML. Cardiac exercise testing. Indications, staff, equipment, conduct and procedures. Neth J Cardiol. 1989;2:63–72. Ascoop CAPL, Van Zeijl LGPM, Pool J, Simoons ML. Cardiac exercise testing. Indications, staff, equipment, conduct and procedures. Neth J Cardiol. 1989;2:63–72.

go back to reference Guazzi M, Adams V, Conraads V, et al. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012;126:2261–74.CrossRefPubMedPubMedCentral Guazzi M, Adams V, Conraads V, et al. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012;126:2261–74.CrossRefPubMedPubMedCentral

go back to reference Bleiziffer S, Eichinger WB, Hettich I, et al. Impact of patient-prosthesis mismatch on exercise capacity in patients after bioprosthetic aortic valve replacement. Heart. 2008;94:637–41.CrossRefPubMed Bleiziffer S, Eichinger WB, Hettich I, et al. Impact of patient-prosthesis mismatch on exercise capacity in patients after bioprosthetic aortic valve replacement. Heart. 2008;94:637–41.CrossRefPubMed

go back to reference Mishra RK, Li Y, Ricardo AC, et al. Association of N‑terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]). Am J Cardiol. 2013;111:432–8.CrossRefPubMed Mishra RK, Li Y, Ricardo AC, et al. Association of N‑terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]). Am J Cardiol. 2013;111:432–8.CrossRefPubMed

go back to reference Meijers WC, Hoekstra T, Jaarsma T, van Veldhuisen DJ, de Boer RA. Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides. Neth Heart J. 2016;24:287–95.CrossRefPubMedPubMedCentral Meijers WC, Hoekstra T, Jaarsma T, van Veldhuisen DJ, de Boer RA. Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides. Neth Heart J. 2016;24:287–95.CrossRefPubMedPubMedCentral

go back to reference Eindhoven JA, Menting ME, van den Bosch AE, et al. Associations between N‑terminal pro-B-type natriuretic peptide and cardiac function in adults with corrected tetralogy of Fallot. Int J Cardiol. 2014;174:550–6.CrossRefPubMed Eindhoven JA, Menting ME, van den Bosch AE, et al. Associations between N‑terminal pro-B-type natriuretic peptide and cardiac function in adults with corrected tetralogy of Fallot. Int J Cardiol. 2014;174:550–6.CrossRefPubMed

go back to reference Luchner A, Behrens G, Stritzke J, et al. Long-term pattern of brain natriuretic peptide and N‑terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors. Eur J Heart Fail. 2013;15:859–67.CrossRefPubMed Luchner A, Behrens G, Stritzke J, et al. Long-term pattern of brain natriuretic peptide and N‑terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors. Eur J Heart Fail. 2013;15:859–67.CrossRefPubMed

go back to reference Luijnenburg SE, Peters RE, van der Geest RJ, et al. Abnormal right atrial and right ventricular diastolic function relate to impaired clinical condition in patients operated for tetralogy of Fallot. Int J Cardiol. 2013;167:833–9.CrossRefPubMed Luijnenburg SE, Peters RE, van der Geest RJ, et al. Abnormal right atrial and right ventricular diastolic function relate to impaired clinical condition in patients operated for tetralogy of Fallot. Int J Cardiol. 2013;167:833–9.CrossRefPubMed

go back to reference van Slooten YJ, van Melle JP, Freling HG, et al. Aortic valve prosthesis patient mismatch and exercise capacity in adult patients with congenital heart disease. Heart. 2016;102:107–13.CrossRefPubMed van Slooten YJ, van Melle JP, Freling HG, et al. Aortic valve prosthesis patient mismatch and exercise capacity in adult patients with congenital heart disease. Heart. 2016;102:107–13.CrossRefPubMed

go back to reference Norozi K, Buchhorn R, Kaiser C, et al. Plasma N‑terminal pro-brain natriuretic peptide as a marker of right ventricular dysfunction in patients with tetralogy of Fallot after surgical repair. Chest. 2005;128:2563–70.CrossRefPubMed Norozi K, Buchhorn R, Kaiser C, et al. Plasma N‑terminal pro-brain natriuretic peptide as a marker of right ventricular dysfunction in patients with tetralogy of Fallot after surgical repair. Chest. 2005;128:2563–70.CrossRefPubMed

go back to reference Bove T, Vandekerckhove K, Devos D, et al. Functional analysis of the anatomical right ventricular components: should assessment of right ventricular function after repair of tetralogy of Fallot be refined? Eur J Cardiothorac Surg. 2014;45:e6–12.CrossRefPubMed Bove T, Vandekerckhove K, Devos D, et al. Functional analysis of the anatomical right ventricular components: should assessment of right ventricular function after repair of tetralogy of Fallot be refined? Eur J Cardiothorac Surg. 2014;45:e6–12.CrossRefPubMed